Thursday 31 May 2018

Reuters Health Report: In China, industry push-back stubs out anti-smoking gains

In China, industry push-back stubs out anti-smoking gains

BEIJING (Reuters) - Earlier this year, the city of Hangzhou, home to the internet giant Alibaba, was poised to join Beijing, Shanghai and a handful of other urban areas in banning smoking in public places, part of a long-running campaign against tobacco use in China.

Indivior subpoenaed by California on opioid addiction treatment

(Reuters) - Britain's Indivior has been subpoenaed by the California Department of Insurance over its blockbuster opioid addiction treatment, Suboxone Film, which is rapidly losing market share due to stiff competition from generic versions.

Nipah virus death toll rises to 15, two new cases found in India's Kerala

KOCHI/MUMBAI (Reuters) - Two new cases of the deadly brain-damaging Nipah virus have been confirmed in the southern Indian state of Kerala, where another two people were killed by the virus, a health official said on Thursday.

Trump says drug companies to announce 'massive' price cuts soon

WASHINGTON (Reuters) - President Donald Trump on Wednesday said he expects major drug companies to slash prices on their products in two weeks, but did not provide details on which companies would do so or how such reductions would be made.

Minnesota sues opioid maker Insys over improper drug marketing

(Reuters) - Minnesota on Wednesday became the latest state to sue Insys Therapeutics Inc , accusing the drugmaker of illegally marketing a powerful fentanyl-based pain medicine, while a former employee pleaded guilty in New Jersey over bribing doctors to prescribe the drug.

FDA clears Pfizer's Xeljanz for inflammatory bowel disease

(Reuters) - The U.S. Food and Drug Administration said on Wednesday that it had approved Pfizer Inc's drug, Xeljanz, to treat adults with moderate-to-severe active ulcerative colitis.

AstraZeneca drug Fasenra fails to achieve main goal in COPD trial

(Reuters) - AstraZeneca's first respiratory biological medicine Fasenra failed to meet its main target in a second clinical trial treating patients with moderate to very severe chronic obstructive pulmonary disease (COPD).

Smoking down, but tobacco use still a major cause of death, disease - WHO

GENEVA (Reuters) - Fewer people are smoking worldwide, especially women, but only one country in eight is on track to meet a target of reducing tobacco use significantly by 2025, the World Health Organization (WHO) said on Thursday.

Genetic obesity risk tied to smoking

(Reuters Health) - Although smoking has long been associated with being thin, a recent genetic study suggests that a tendency to have excess body fat, especially around the waist, is also tied to a person's odds of being a smoker.

Stressed out middle-aged workers have higher risk of mental health issues

(Reuters Health) - Middle-aged adults who feel stressed, powerless or overworked on the job may be more likely to develop mental health problems in the coming years than more contented coworkers, a recent study suggests.

Related Videos

Gravity energy generator could revolutionise renewables

Slovene beekeepers hope to have a stinging impact on bee preservation

You might like...

Check out our Reuters News Now daily briefing for hand-picked stories from Reuters editors. It's all the news you need to start your day.

Subscribe here